TY - JOUR
KW - Advanced care practitioners
KW - buprenorphine
KW - Collaboration
KW - Medications for opioid use disorder
KW - Nurse Practitioners
KW - opioid use disorder
KW - Physician assistants
KW - scope of practice
KW - State law
KW - Supervision
KW - Waiver
AU - B. Andraka-Christou
AU - A. J. Gordon
AU - J. Spetz
AU - R. Totaram
AU - M. Golan
AU - O. Randall-Kosich
AU - J. Harrison
AU - S. Calder
AU - S. G. Kertesz
AU - B. D. Stein
A1 - 
AD - School of Health Management & Informatics, University of Central Florida, Orlando, FL, United States of America; Department of Internal Medicine, University of Central Florida, Orlando, FL, United States of America. Electronic address: barbara.andraka@ucf.edu.; Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation, VA Salt Lake City Health Care System, Salt Lake City, UT, United States of America; Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Vulnerable Veteran Innovative PACT (VIP) Initiative, VA Salt Lake City Health Care System, Salt Lake City, UT, United States of America.; Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, CA, United States of America.; School of Health Management & Informatics, University of Central Florida, Orlando, FL, United States of America.; School of Law, Emory University, Atlanta, GA, United States of America.; School of Public Health, Georgia State University, Atlanta, GA, United States of America.; RAND Corporation, Pittsburgh, PA, United States of America.; Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation, VA Salt Lake City Health Care System, Salt Lake City, UT, United States of America; Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Vulnerable Veteran Innovative PACT (VIP) Initiative, VA Salt Lake City Health Care System, Salt Lake City, UT, United States of America.; Birmingham, Alabama VA Health Care System, Birmingham, AL, United States of America; Division of Preventive Medicine, University of Alabama, Birmingham, AL, United States of America.; RAND Corporation, Pittsburgh, PA, United States of America.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2021.108715
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2022
SN - 1873-6483; 0740-5472
SP - 108715
T1 - Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing
T2 - Journal of substance abuse treatment
TI - Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing
U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
U2 - 35067400
U3 - 10.1016/j.jsat.2021.108715
VO - 1873-6483; 0740-5472
Y1 - 2022
Y2 - Jan 10
ER -